Search clinical trials for: Salbutamol sulfate/Ipratropium bromide

Total 121 results

Boehringer Ingelheim

Completed

Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD

Pulmonary Disease, Chronic Obstructive
Hat Yai Medical Education Center

Recruiting

Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study) (PARASMA)

Asthma | Airway Obstruction | Airway Remodeling | Parasympathetic Nervous System Diseases

Thailand
Laval University
Institut universitaire de cardiologie et de pneumologie de Québec, University...

Unknown

Glittre ADL-test: Responsiveness to Acute Bronchodilation in Chronic Obstructive Pulmonary Disease (COPD) (Glittre)

Chronic Obstructive Pulmonary Disease

Canada
Boehringer Ingelheim

Completed

Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm

Asthma
Universidade Federal do Rio Grande do Norte

Unknown

Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized Bronchodilator

Asthma | COPD

Brazil
Boehringer Ingelheim

Terminated

Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis

Asthma
Boehringer Ingelheim

Completed

Study to Assess the Safety of Ipratropium Bromide, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
Assistance Publique - Hôpitaux de Paris

Withdrawn

Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension (BD-HTAP)

Pulmonary Arterial Hypertension
Boehringer Ingelheim

Completed

Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive
Pneuma Respiratory, Inc

Completed

Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD

COPD

United States
The First Affiliated Hospital of Guangzhou Medical...

Recruiting

Neural Respiratory Drive of Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

China
University Hospital, Antwerp
GlaxoSmithKline

Completed

Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients

COPD

Belgium
Boehringer Ingelheim

Terminated

Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children

Asthma
State University of New York at Buffalo
National Center for Advancing Translational Sciences (NCATS)

Completed

Defining and Treating Depression-related Asthma

Depression | Asthma | Childhood Asthma

United States
Boehringer Ingelheim

Completed

A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

China
Haukeland University Hospital

Completed

Atrovent in Exercise Induced Laryngeal Obstruction (EILO)

Exercise Induced Laryngeal Obstruction (EILO)

Norway
University Health Network, Toronto
Parkinson's Disease Foundation

Completed

Ipratropium Spray for Drooling Saliva in Parkinson's Disease

Parkinson's Disease

Canada
Boehringer Ingelheim

Completed

Actuation Indicator Trial in Patients With COPD

Pulmonary Disease, Chronic Obstructive

United States
Imperial College London
GlaxoSmithKline

Terminated

Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways Disease

Chronic Obstructive Pulmonary Disease

United Kingdom
Zhujiang Hospital
Guangzhou Panyu Central Hospital

Completed

Ventilation-drive Coupling to Evaluate The Efficacy of Inhaled Bronchodilators in Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

China
University of California, San Francisco

Completed

Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes (STAMINA)

Bronchospasm, Exercise-Induced

United States
Queen's University

Completed

Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Canada
London Health Sciences Centre

Unknown

Ipratropium Bromide Spray as Treatment for Sialorrhea in Children

Sialorrhea
GlaxoSmithKline
University College London Hospitals

Completed

Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease

Lung Diseases, Interstitial

United Kingdom
Sunovion Respiratory Development Inc.

Completed

Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study

Chronic Obstructive Pulmonary Disease

United States, United Kingdom
Boehringer Ingelheim

Completed

Ipratropium Bromide in Peri-Operative COPD

Pulmonary Disease, Chronic Obstructive

China
University of Saskatchewan
Royal University Hospital Foundation

Completed

Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness

Asthma

Canada
University of California, Los Angeles
Mylan Pharmaceuticals Inc; Theravance Biopharma

Recruiting

Revefenacin in Acute Respiratory Insufficiency in COPD (RARICO)

COPD | Acute Respiratory Failure

United States
Centre for Addiction and Mental Health

Completed

Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide

Hypersalivation

Canada
Boehringer Ingelheim

Completed

Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.

Pulmonary Disease, Chronic Obstructive

United States, Argentina, Lithuania, Slovakia, United Kingdom
Pearl Therapeutics, Inc.

Completed

PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United States
ThromboGenics

Terminated

Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion

Arterial Occlusive Diseases

Belgium
Laval University
McGill University; Boehringer Ingelheim

Completed

Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

Canada
ThromboGenics
Bacchus Vascular

Terminated

Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT (MAX-DVT)

Deep Vein Thrombosis

Ireland
NYU Langone Health

Completed

The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia

Familial Dysautonomia

United States
GlaxoSmithKline

Completed

Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers.

Asthma

Australia
Nycomed

Completed

Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)

Common Cold
Boehringer Ingelheim

Completed

Trial to Determine the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to ATROVENT® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
University of Monastir

Completed

Magnesium Sulfate Versus Ipratropuim Bromide in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

COPD Exacerbation

Tunisia
Dey

Completed

A Crossover Study in the Treatment of Patients With COPD

Chronic Obstructive Pulmonary Disease

United States
Boehringer Ingelheim

Completed

Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg)

Asthma

Philippines
Oregon Health and Science University
Wake Forest University Health Sciences; University at Buffalo; University of...

Recruiting

Treating Respiratory Emergencies in Children Study (T-RECS)

Asthma in Children

United States
Pharmaxis

Completed

Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD

Lung Diseases, Obstructive

Australia
Northwell Health
AstraZeneca; Jacobi Medical Center; Nassau University Medical Center

Completed

Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.

Asthma

United States
Queen's University

Completed

Bronchodilators and Oxygen Kinetics With Exercise in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease

Canada
snow
Primary-investigator,Bing Sun

Unknown

Airway Responsiveness in Patients With AECOPD Mechanical Ventilation by Inspiratory and Bronchial Dilation Testchronic Obstructive Pulmonary Disease

Lung Disease,Obstructive

China
Boehringer Ingelheim

Completed

Comparative Pharmacokinetics and Pharmacodynamics of Tiotropium With Ipratropium or Placebo After 19 Days of Tiotropium Treatment

Healthy

3

Subscribe